** Shares in Swiss dental implant maker Straumann STMN.S are
seen down 2.4% in Julius Baer's premarket indicator after the
company released third-quarter sales report
** Sales were in line with estimates, Vontobel analysts say,
but point out that the 2% growth in the U.S. was below
expectations
** "It was somewhat disappointing," Vontobel says
** Investors had expected North America to not disappoint,
given the limited visibility for 2025 on the fast-growing
Chinese market, a London-based trader says
** Vontobel remarks the robust sale performance in the
Asia-Pacific region and Europe, Middle East and Africa market
** The stock has lost 6.0% year-to-date
(Reporting by Alberto Chiumento)
((Alberto.Chiumento@thomsonreuters.com;))